6185 — Cansino Biologics Share News
0.000.00%
Last trade - 00:00- HK$5.73bn
- HK$4.18bn
- CNY1.06bn
Brief: JPMorgan's Long Position In H-Shares Of CanSino Falls To 10.97% - HKEX Filing
Brief: JPMorgan's Long Position In H-Shares Of CanSino Biologics Rises To 11.05% - HKEX Filing
China's vaccine group CanSino HK stock at over 5-months low amid yearly loss
Brief: Cansino Biologics Swings To Net Loss Of 909.4 Mln Yuan In 2022
Brief: JPMorgan's Long Position In H-Shares Of CanSino Biologics Falls To 9.98% - HKEX Filing
Brief: JPMorgan's Long Position In H-Shares Of CanSino Rises To 10.04% - HKEX Filing
Brief: CanSino Biologics' Inhalable COVID Vaccine Obtains EUA In Indonesia
Brief: CanSino Biologics Swings Prelim 2022 Net Loss Of 901.9 Mln Yuan
Brief: Capital Group Companies Inc's Long Position In H-Shares Of CanSino Rises To 21.14% - Filing
Brief: Capital Group Companies' Long Position In H-Shares Of CanSino Rises To 19.48% - HKEX Filing
China's CanSino confident its mRNA COVID vaccine as good as Moderna, Pfizer shots (updated)
China's CanSino confident its mRNA COVID vaccine as good as Moderna, Pfizer shots
China's CanSino falls on downbeat forecast as demand for COVID vaccines drop
Brief: JPMorgan's Long Position In H-Shares Of CanSino Biologics Falls To 8.60% - HKEX Filing
Brief: JPMorgan's Long Position In H-Shares Of CanSino Rises To 9.06% - HKEX Filing
Brief: Cansino Biologics Agreed To Purchase Structured Deposit In Principal Amount Of Rmb200 Million From China Bohai Bank
Brief: CanSino Biologics Plans GDRs Issue In Switzerland
Wrapup 2: China's 'great migration' kicks-off under shadow of COVID
China's 'great migration' kicks-off under shadow of COVID